Anti-HIV Immunoglobulin (HIVIG) in Prevention of Maternal-Fetal HIV Transmission (Pediatric ACTG Protocol 185)
Completed
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Phase 3
1991-09-01
To determine if HIV hyperimmune globulin (HIVIG) given to HIV-positive pregnant women during
the second and third trimester of pregnancy reduced the likelihood of maternal-fetal HIV
transmission. Conducted in collaboration with the National Institute of Child Health and
Human Development and the National Institute of Allergy and Infectious Diseases. The trial
was Pediatric ACTG Protocol 185.
Anti-HIV Immunoglobulin (HIVIG) in Prevention of Maternal-Fetal HIV Transmission (Pediatric ACTG Protocol 185)
Completed
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 3
1991-09-01
To determine if HIV hyperimmune globulin (HIVIG) given to HIV-positive pregnant women during
the second and third trimester of pregnancy reduced the likelihood of maternal-fetal HIV
transmission. Conducted in collaboration with the National Institute of Child Health and
Human Development and the National Institute of Allergy and Infectious Diseases. The trial
was Pediatric ACTG Protocol 185.
Anti-HIV Immunoglobulin (HIVIG) in Prevention of Maternal-Fetal HIV Transmission (Pediatric ACTG Protocol 185)
Completed
National Heart, Lung, and Blood Institute (NHLBI)
Phase 3
1991-09-01
To determine if HIV hyperimmune globulin (HIVIG) given to HIV-positive pregnant women during
the second and third trimester of pregnancy reduced the likelihood of maternal-fetal HIV
transmission. Conducted in collaboration with the National Institute of Child Health and
Human Development and the National Institute of Allergy and Infectious Diseases. The trial
was Pediatric ACTG Protocol 185.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
